Medpace Holdings (MEDP) Accumulated Expenses (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Accumulated Expenses data on file, last reported at $451.1 million in Q2 2026.

• Quarterly Accumulated Expenses rose 39.43% year-over-year to $451.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $451.1 million (up 39.43% YoY) and the FY2025 annual result came in at $408.4 million, up 32.67% from the prior year.
• Accumulated Expenses rose to $451.1 million in Q2 2026, from $406.1 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $451.1 million in Q2 2026 to a low of $155.0 million in Q1 2022.
• A 5-year average of $286.4 million and a median of $289.4 million in 2024 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2024 — Accumulated Expenses gained 5.07% — and 2026, when it jumped 41.93%.
• Tracing MEDP's Accumulated Expenses over 5 years: stood at $210.1 million in 2022, then soared by 39.42% to $293.0 million in 2023, then increased by 5.07% to $307.8 million in 2024, then surged by 32.67% to $408.4 million in 2025, then climbed by 10.45% to $451.1 million in 2026.
• The last three Accumulated Expenses figures came in at $451.1 million (Q2 2026), $406.1 million (Q1 2026), and $408.4 million (Q4 2025), per Business Quant data.